Related Experiment Video
Updated: Aug 11, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
Effect of atropine on mucociliary transport velocity in anesthetized dogs
Abstract:
We recently described a radioactive tracer method of measuring mucociliary transport rates (MCTR) in vivo in dogs. The distance from larynx to carina is measured on inserting a calibrated fiberoptic bronchoscope into the trachea. A small volume (0.04 to 0.1 ml) of a suspension of radio-labeled albumin microspheres 5 to 7 micrometer in diameter is then deposited on the mucosal surface at the carina via a catheter placed through the inner channel of the bronchoscope. The rate of movement of these sphere towards the larynx is visualized sequentially by means of a gamma scintillation camera with a large field of view and is recorded as polaroid images during 10 to 30 min. By using this technique, transport rates were determined in the tracheas of 10 anesthetized dogs (17 experiments) before and 10 min after intravenous infusion of 0.4 mg of atropine sulfate; each animal served as its own control subject. Baseline MCTR values were determined by using microspheres labeled with 140-KeV technetium-99m. After infusion of atropine, MCTR values were again determined using micropheres labeled with 390-KeV indium-113m. Because of their widely differing energy spectrums, both test agents could be used in rapid succession by adjusting the spectrometer of the scintillation camera. MCTR increased in 13 experiments, did not change in two, and decreased in two. The percentage increase in MCTR after infusion of atropine was significant as compared to baseline values (30.0 +/- 0.6 per cent, mean +/- SE; P less than 0.05 by paired t test), as was the absolute change in MCTR after infusion of atropine (P less than 0.05 by 2-way analysis of variance). Therefore, the effect of atropine in improving mucociliary clearance was quantitatively similar to that previously reported for beta-adrenergic agonists.
Related Concept Videos
Direct-Acting Cholinergic Agonists: Pharmacological Actions
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Cholinergic Antagonists: Pharmacological Actions
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...

